Drugs / [13C9, 15N1]-glucagon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07818707 | Jan 2026 → Jan 2027 expected | hypoglycemia | Joslin Diabetes Center | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [13C9, 15N1]-glucagon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07818707 ↗ |